Literature DB >> 23049337

HIV Seroconversion in blood donors from the coordinating blood bank in the State of Pará.

Andrea Silvestre Lobão Costa1, Danielle Murici Brasiliense.   

Abstract

BACKGROUND: Transfusion of Human immunodeficiency virus (HIV) infected blood is probably the most effective means of transmission of this disease. Despite intense efforts and investment to ensure safety, transmission of HIV still remains a real possibility in the transfusion service due to the fact that routine laboratory tests in most Brazilian government blood banks rely on the detection of antibodies. This leaves an immunological window period of from 16 to 22 days, which could be minimized to approximately 9 to 11 days if nucleic acid amplification tests were employed in screening.
OBJECTIVE: To analyze the profile of blood donors who seroconverted to HIV positive from 2008 to 2010 in the coordinating blood bank of the State of Pará in respect to gender, age, marital status and educational level.
METHODS: HIV seroconversion cases of blood donors who donated on more than one occasion at the coordinating blood bank of the State of Pará were investigated. Records from 2008 and 2010 were analyzed in respect to gender, marital status, schooling and age.
RESULTS: Among the 157,432 donations in this period, 45 HIV seroconversions were confirmed. Of these, 95.56% were men, of which 86.67% were single, 53.33% had completed high school and 40% were between 23 and 29 years old.
CONCLUSIONS: In order to improve the quality of blood and reduce the residual risk of HIV transmission in blood banks, it is necessary to know the profiles of donors who most frequently seroconvert and use nucleic acid amplification tests as routine screening.

Entities:  

Keywords:  Blood donors; HIV; HIV seropositivity; Risk factors

Year:  2011        PMID: 23049337      PMCID: PMC3415779          DOI: 10.5581/1516-8484.20110096

Source DB:  PubMed          Journal:  Rev Bras Hematol Hemoter        ISSN: 1516-8484


  11 in total

1.  Blood donors with 'medium' or 'minor' risk factors for human immunodeficiency virus infection: are they eligible for donation?

Authors:  C Silvani; L Vianello; P Rebulla; D Prati; F Mozzi; E Taioli; G Sirchia
Journal:  Haematologica       Date:  2000-10       Impact factor: 9.941

2.  HIV seroconverting donors delay their return: screening test implications.

Authors:  George B Schreiber; Simone A Glynn; Glen A Satten; Fanhui Kong; David Wright; Michael P Busch; Yongling Tu; Steven H Kleinman
Journal:  Transfusion       Date:  2002-04       Impact factor: 3.157

3.  Transfusion risk for hepatitis B, hepatitis C and HIV in the state of Santa Catarina, Brazil, 1991-2001.

Authors:  Emil Kupek
Journal:  Braz J Infect Dis       Date:  2004-09-29       Impact factor: 1.949

4.  Human immunodeficiency virus, hepatitis C and hepatitis B infections among blood donors in Germany 2000-2002: risk of virus transmission and the impact of nucleic acid amplification testing.

Authors:  R Offergeld; D Faensen; S Ritter; O Hamouda
Journal:  Euro Surveill       Date:  2005-02

5.  Fourth-generation enzyme-linked immunosorbent assay for the simultaneous detection of human immunodeficiency virus antigen and antibody.

Authors:  R D Saville; N T Constantine; F R Cleghorn; N Jack; C Bartholomew; J Edwards; P Gomez; W A Blattner
Journal:  J Clin Microbiol       Date:  2001-07       Impact factor: 5.948

6.  Failure of routine HIV-1 tests in a case involving transmission with preseroconversion blood components during the infectious window period.

Authors:  A E Ling; K E Robbins; T M Brown; V Dunmire; S Y Thoe; S Y Wong; Y S Leo; D Teo; J Gallarda; B Phelps; M E Chamberland; M P Busch; T M Folks; M L Kalish
Journal:  JAMA       Date:  2000-07-12       Impact factor: 56.272

7.  Risk behaviors in volunteer blood donors who seroconverted for HIV, Abidjan, Côte d'Ivoire 1997 to 2005.

Authors:  Albert Minga; Lambert Dohoun; Yao Abo; Ali Coulibaly; Seidou Konaté; Hervé Penan Ouattara; Bath K N'guessan; François Dabis; Roger Salamon; Charlotte Lewden
Journal:  Transfusion       Date:  2009-11-20       Impact factor: 3.157

8.  Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing.

Authors:  Susan L Stramer; Simone A Glynn; Steven H Kleinman; D Michael Strong; Sally Caglioti; David J Wright; Roger Y Dodd; Michael P Busch
Journal:  N Engl J Med       Date:  2004-08-19       Impact factor: 91.245

9.  Risk of HIV infection from transfusion with blood negative for HIV antibody in a west African city.

Authors:  D Savarit; K M De Cock; R Schutz; S Konate; E Lackritz; A Bondurand
Journal:  BMJ       Date:  1992-08-29

10.  Window-period human immunodeficiency virus transmission to two recipients by an adolescent blood donor.

Authors:  Ruby Phelps; Kenneth Robbins; Thomas Liberti; Ana Machuca; German Leparc; Mary Chamberland; Marcia Kalish; Indira Hewlett; Thomas Folks; Lisa M Lee; Matthew McKenna
Journal:  Transfusion       Date:  2004-06       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.